UConn Health patients with advanced melanoma are benefiting from the same drug credited recently for the disappearance of the disease in former President Jimmy Carter.

Physicians with the Carole and Ray Neag Comprehensive Cancer Center at UConn Health are successfully boosting the immune system of some of their advanced melanoma patients by using a new and promising immunotherapy tool called Keytruda (pembrolizumab) to help them fight the aggressive disease.